Gary Layton
Impact in
-
- Pulmonary Hypertension Research and Treatments
- Respiratory and Cough-Related Research
-
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
Papers in
-
- HIV/AIDS drug development and treatment 6
- Antifungal resistance and susceptibility 5
-
- Pulmonary Hypertension Research and Treatments 6
- Co-authors
- Robyn J. Barst (4 shared papers)Kimberley Holt (2 shared papers)Rayid Abdulqawi (2 shared papers)Bruce G. McCarthy (2 shared papers)Anthony Ford (2 shared papers)Rachel Dockry (2 shared papers)John A. Smith (1 shared paper)Tomás Pulido (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (11 papers)European Journal of Clinical Pharmacology (3 papers)Circulation (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Neuromuscular Disorders (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Gary Layton
44 papers receiving 2.0k citations
Gary Layton's Hit Papers
Peers
Comparison fields: 5 of 102
- Pulmonary and Respiratory Medicine 827
- Cardiology and Cardiovascular Medicine 417
- Physiology 81
- Physiology 345
- Sensory Systems 65
Countries citing papers authored by Gary Layton
This map shows the geographic impact of Gary Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Layton more than expected).
Fields of papers citing papers by Gary Layton
This network shows the impact of papers produced by Gary Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Layton. The network helps show where Gary Layton may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study Hit paper breakdown → | 2014 | 358 |
| 2 | 2011 | 275 | |
| 3 | 2011 | 200 | |
| 4 | 2014 | 149 | |
| 5 | 2017 | 140 | |
| 6 | 2009 | 111 | |
| 7 | 2018 | 104 | |
| 8 | 2003 | 88 | |
| 9 | 2006 | 65 | |
| 10 | 2010 | 56 | |
| 11 | 2016 | 49 | |
| 12 | 2019 | 35 | |
| 13 | 2009 | 34 | |
| 14 | 1997 | 33 | |
| 15 | 1998 | 32 | |
| 16 | 2003 | 28 | |
| 17 | 2007 | 27 | |
| 18 | 2004 | 27 | |
| 19 | 2014 | 26 | |
| 20 | 2019 | 24 |
About Gary Layton
Gary Layton is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology, Psychiatry and Mental health and Surgery, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Pulmonary Hypertension Research and Treatments (6 papers), Antifungal resistance and susceptibility (5 papers), Muscle Physiology and Disorders (5 papers), Migraine and Headache Studies (4 papers), Biotin and Related Studies (3 papers), Pituitary Gland Disorders and Treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (827 citations), Cardiology and Cardiovascular Medicine (417 citations), Physiology (81 citations), Physiology (345 citations) and Sensory Systems (65 citations). Gary Layton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robyn J. Barst, Kimberley Holt, Rayid Abdulqawi, Bruce G. McCarthy, Anthony Ford, Rachel Dockry, John A. Smith, Tomás Pulido, D. Dunbar Ivy and Marjana Serdarevic-Pehar. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Circulation, Antimicrobial Agents and Chemotherapy and Neuromuscular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.